HLA-B*5701 screening for hypersensitivity to abacavir

Author： Faruki Hawazin   Lai-Goldman Myla  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.5, Iss.3, 2008-05, pp. : 297-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA-B*5701 screening prior to abacavir prescription: Clinical and laboratory aspects

By Nolan David  

Critical Reviews in Clinical Laboratory Sciences, Vol. 46, Iss. 3, 2009-06 ,pp. : 153-165

Informa Healthcare

Access to resources Recommend Favorite

HLA‐A*31:01 and HLA‐B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 142-149

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel HLA‐B allele, HLA‐B*35:269

By  

HLA, Vol. 87, Iss. 2, 2016-02 ,pp. : 107-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel HLA‐B allele: HLA‐B*40:241

By  

HLA, Vol. 91, Iss. 2, 2018-02 ,pp. : 138-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of a new HLA‐B allele, HLA‐B*15:300, in a Chinese individual

By  

HLA, Vol. 87, Iss. 3, 2016-03 ,pp. : 175-176

John Wiley & Sons Inc

Access to resources Recommend Favorite